Two titans are speeding change
Both retail titans are moving with alacrity to reinvent their core business, even as they invest billions of dollars in other relevant fields — most notably artificial intelligence.
Both retail titans are moving with alacrity to reinvent their core business, even as they invest billions of dollars in other relevant fields — most notably artificial intelligence.
What makes this moment particularly challenging is that consumers are not simply “trading down” in the traditional sense. They are redefining value altogether.
David Pinto does a postmortem of the NACDS Annual and looks for areas to improve the event.
Other new research, from Acosta Group, reveals that GLP-1s are reshaping consumer behavior including lifestyle, health and wellness, and personal care choices.
The entire system would benefit from directing consumers to the lowest-cost point of care.
AI is reshaping how consumers shop and how retailers compete. But as the technology grows more powerful, a critical question is emerging: How much AI is too much?
David Pinto looks at where NACDS needs to make some changes to meet its future destiny.
By Thom Blischok, chairman and chief executive officer of the Dialogic Group LLC.
By Steve Anderson, president and chief executive officer of the National Association of Chain Drug Stores.
By Ed Rowland, principal of Rowland Global LLC.
By Krystal Register, VP of health and well-being at FMI – The Food Industry Association
By Paula Bellostas Muguerz, global lead of the Healthcare and Life Sciences practice at Kearney, and Anna Bode, global head of the Kearney Health Institute.
By Georgia Gums, product and strategic pricing analyst at HRG.
Kristin Hornberger, executive vice president and practice leader for wellness, beauty and homecare at Circana.
By Jill Standish, global retail lead at Accenture